These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36056847)

  • 1. Fibromyalgia in Spondyloarthritis: Prevalence and Effect on Disease Activity and Treatment.
    Olfa S; Bouden S; Sahli M; Tekaya AB; Rouached L; Rawdha T; Mahmoud I; Abdelmoula L
    Curr Rheumatol Rev; 2023; 19(2):214-221. PubMed ID: 36056847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice.
    Wach J; Letroublon MC; Coury F; Tebib JG
    J Rheumatol; 2016 Nov; 43(11):2056-2063. PubMed ID: 27633820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of Fibromyalgia Syndrome and Its Relationship with Clinical Parameters in Patients with Axial Spondyloarthritis.
    Rencber N; Saglam G; Huner B; Kuru O
    Pain Physician; 2019 Nov; 22(6):E579-E585. PubMed ID: 31775411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study.
    Moltó A; Etcheto A; Gossec L; Boudersa N; Claudepierre P; Roux N; Lemeunier L; Martin A; Sparsa L; Coquerelle P; Soubrier M; Perrot S; Dougados M
    Ann Rheum Dis; 2018 Apr; 77(4):533-540. PubMed ID: 29183878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity.
    Salaffi F; De Angelis R; Carotti M; Gutierrez M; Sarzi-Puttini P; Atzeni F
    Rheumatol Int; 2014 Aug; 34(8):1103-10. PubMed ID: 24509896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis.
    Provan SA; Dean LE; Jones GT; Macfarlane GJ
    Rheumatology (Oxford); 2021 Sep; 60(9):4121-4129. PubMed ID: 34469570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fibromyalgia on the disease activity and treatment of patients with axial spondyloarthritis.
    Gao R
    J Musculoskelet Neuronal Interact; 2021 Sep; 21(3):440-446. PubMed ID: 34465685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis.
    Bello N; Etcheto A; Béal C; Dougados M; Moltó A
    Arthritis Res Ther; 2016 Feb; 18():42. PubMed ID: 26860612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the performance of extreme patient-reported outcomes as surrogate markers for fibromyalgia in axial spondyloarthritis.
    Santos-Faria D; Dougados M; Gossec L; Perrot S; Moltó A
    Rheumatol Int; 2019 Jan; 39(1):141-146. PubMed ID: 30413924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Metrology in Axial Spondyloarthritis: Does It Provide Unique Information in Assessing Patients and Predicting Outcome? Results From the British Society for Rheumatology Biologic Register for Ankylosing Spondylitis.
    Biallas RL; Dean LE; Davidson L; Hollick R; Pathan E; Robertson L; Jones GT; Macfarlane GJ; Rotariu O
    Arthritis Care Res (Hoboken); 2022 Apr; 74(4):665-674. PubMed ID: 33140891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register.
    Macfarlane GJ; MacDonald RIR; Pathan E; Siebert S; Gaffney K; Choy E; Packham J; Martin KR; Haywood K; Sengupta R; Atzeni F; Jones GT
    Rheumatology (Oxford); 2018 Nov; 57(11):1982-1990. PubMed ID: 30053166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
    Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
    Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration.
    Ørnbjerg LM; Linde L; Georgiadis S; Rasmussen SH; Lindström U; Askling J; Michelsen B; Giuseppe DD; Wallman JK; Pavelka K; Závada J; Nissen MJ; Jones GT; Relas H; Pirilä L; Tomšič M; Rotar Z; Geirsson AJ; Gudbjornsson B; Kristianslund EK; van Sder Horst-Bruinsma I; Loft AG; Laas K; Iannone F; Corrado A; Ciurea A; Santos MJ; Santos H; Codreanu C; Akkoc N; Gunduz OS; Glintborg B; Østergaard M; Hetland ML
    Semin Arthritis Rheum; 2022 Oct; 56():152081. PubMed ID: 35985172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of enthesitis indices with disease activity and function in axial and peripheral spondyloarthritis: a cross-sectional study comparing MASES, SPARCC and LEI.
    Palominos PE; de Campos APB; Ribeiro SLE; Xavier RM; Xavier JW; de Oliveira FB; Guerra B; Saldanha C; Mancuso ACB; Kohem CL; Gasparin AA; Sampaio-Barros PD
    Adv Rheumatol; 2019 Jun; 59(1):23. PubMed ID: 31208465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is fibromyalgia frequency increasing in axial spondyloarthritis? Association with fibromyalgia and biological therapies.
    Sayın S; Yurdakul FG; Sivas F; Bodur H
    Rheumatol Int; 2020 Nov; 40(11):1835-1841. PubMed ID: 32767083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Axial Spondyloarthritis Among Patients With Fibromyalgia: A Magnetic Resonance Imaging Study With Application of the Assessment of SpondyloArthritis International Society Classification Criteria.
    Ablin JN; Eshed I; Berman M; Aloush V; Wigler I; Caspi D; Likhter M; Wollman J; Paran D; Anouk M; Elkayam O
    Arthritis Care Res (Hoboken); 2017 May; 69(5):724-729. PubMed ID: 27390225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors.
    Monti S; Todoerti M; Codullo V; Favalli EG; Biggioggero M; Becciolini A; Montecucco C; Caporali R
    Mod Rheumatol; 2018 May; 28(3):542-549. PubMed ID: 28880727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue in patients with spondyloarthritis associates with disease activity, quality of life and inflammatory bowel symptoms.
    Stebbings SM; Treharne GJ; Jenks K; Highton J
    Clin Rheumatol; 2014; 33(10):1467-74. PubMed ID: 24322832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry.
    Bodur H; Yurdakul FG; Ataman S; Cay HF; Gurer G; Capkin E; Sezer İ; Duruoz MT; Melikoglu MA; Rezvani A; Yagci I; Gogus F; Kamanli A; Akgul O; Cevik R
    Clin Rheumatol; 2022 Jul; 41(7):2053-2063. PubMed ID: 35353263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study.
    Llop M; Gratacós J; Moreno M; Arevalo Salaet M; Calvet J; Berenguer-Llergo A; Dougados M; Molto A; López-Medina C
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.